LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 62.66 | 771.67 | 1485 | 8978 | 0.1654 | 0.2031 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 62.66 | 771.67 | 1667 | 8978 | 0.1857 | 0.2430 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 64.88 | 771.67 | 1473 | 9447 | 0.1559 | 0.1959 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 64.88 | 771.67 | 1672 | 9447 | 0.1770 | 0.2386 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.10 | 771.67 | 1477 | 9800 | 0.1507 | 0.1937 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 67.10 | 771.67 | 1720 | 9800 | 0.1755 | 0.2443 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 69.32 | 771.67 | 1476 | 10212 | 0.1445 | 0.1901 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 69.32 | 771.67 | 1760 | 10212 | 0.1723 | 0.2477 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 71.54 | 771.67 | 1468 | 10532 | 0.1394 | 0.1860 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 71.54 | 771.67 | 1763 | 10532 | 0.1674 | 0.2450 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 73.76 | 771.67 | 1406 | 10851 | 0.1296 | 0.1704 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 73.76 | 771.67 | 1778 | 10851 | 0.1638 | 0.2447 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 76.02 | 771.67 | 1408 | 11106 | 0.1268 | 0.1692 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 76.02 | 771.67 | 1780 | 11106 | 0.1603 | 0.2427 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 78.25 | 771.67 | 1411 | 11367 | 0.1241 | 0.1683 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 78.25 | 771.67 | 1831 | 11367 | 0.1611 | 0.2494 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 80.48 | 771.67 | 1389 | 11685 | 0.1189 | 0.1618 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 80.48 | 771.67 | 1837 | 11685 | 0.1572 | 0.2476 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.69 | 771.67 | 1379 | 11974 | 0.1152 | 0.1581 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 82.69 | 771.67 | 1857 | 11974 | 0.1551 | 0.2486 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 84.92 | 771.67 | 1376 | 12266 | 0.1122 | 0.1560 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 84.92 | 771.67 | 1860 | 12266 | 0.1516 | 0.2467 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.14 | 771.67 | 1352 | 12592 | 0.1074 | 0.1494 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.14 | 771.67 | 1837 | 12592 | 0.1459 | 0.2402 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 2.49 | 771.67 | 816 | 867 | 0.9404 | 0.3909 | MN20160304_L01 | E13 |